http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102482236-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd7c27b9ec61781656e6f039702fd568
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-33
filingDate 2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f551fa82b0e19bd5f8fab5bc3bf38bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6dd85cc410a4cc240b04a08c64db994
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a247acd9cec317cee84179e96cb1f1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92a07d4d44df53e30b5cb7a6b7ffa47d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed1dbc38f7ccc158ce57ec757b275b2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f5bbc93d8819377b43fb396f25ec47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ef252ef9370a43eba12ebd28fe24ff0
publicationDate 2012-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102482236-A
titleOfInvention Indenone derivative and pharmaceutical composition comprising same
abstract An indenone derivative of formula (1) is effective in enhancing the activity of osteoblastic cells and inhibiting bone resorption by osteoclastic cells, and a pharmaceutical composition comprising the indenone derivative or a pharmaceutically acceptable salt thereof is useful for preventing or treating bone diseases such as osteoporosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108912103-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107964009-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106117216-A
priorityDate 2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421627963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422154797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421044530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68181387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70313614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467407514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21865204

Total number of triples: 42.